Skip to Main Content

Paper Details

CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts.
Alzheimers Dement
397
2018
Author NameAffiliation
John Q TrojanowskiCenter for Neurodegenerative Disease Research, Institute on Aging and Department of Pathology and Laboratory Medicine
Christina Rabe
Leslie M ShawPerelman School of Medicine, University of Pennsylvania
  • 1 - 3

Datasets

Release 1.2